807 related articles for article (PubMed ID: 28830479)
1. Costs and expected gain in lifetime health from intensive care versus general ward care of 30,712 individual patients: a distribution-weighted cost-effectiveness analysis.
Lindemark F; Haaland ØA; Kvåle R; Flaatten H; Norheim OF; Johansson KA
Crit Care; 2017 Aug; 21(1):220. PubMed ID: 28830479
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of hip protector use on a geriatric ward in Germany: a Markov model.
Stollenwerk B; Bartmus T; Klug F; Stock S; Müller D
Osteoporos Int; 2015 Apr; 26(4):1367-79. PubMed ID: 25572047
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of national mandatory screening of all admissions to English National Health Service hospitals for meticillin-resistant Staphylococcus aureus: a mathematical modelling study.
Robotham JV; Deeny SR; Fuller C; Hopkins S; Cookson B; Stone S
Lancet Infect Dis; 2016 Mar; 16(3):348-56. PubMed ID: 26616206
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of intensive care for hospitalized COVID-19 patients: experience from South Africa.
Cleary SM; Wilkinson T; Tamandjou Tchuem CR; Docrat S; Solanki GC
BMC Health Serv Res; 2021 Jan; 21(1):82. PubMed ID: 33482807
[TBL] [Abstract][Full Text] [Related]
5. Implications of ICU triage decisions on patient mortality: a cost-effectiveness analysis.
Edbrooke DL; Minelli C; Mills GH; Iapichino G; Pezzi A; Corbella D; Jacobs P; Lippert A; Wiis J; Pesenti A; Patroniti N; Pirracchio R; Payen D; Gurman G; Bakker J; Kesecioglu J; Hargreaves C; Cohen SL; Baras M; Artigas A; Sprung CL
Crit Care; 2011; 15(1):R56. PubMed ID: 21306645
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis.
Mac S; Fitzpatrick T; Johnstone J; Sander B
Antimicrob Resist Infect Control; 2019; 8():168. PubMed ID: 31687132
[TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness of Laparoscopic Hysterectomy With Morcellation Compared With Abdominal Hysterectomy for Presumed Myomas.
Rutstein SE; Siedhoff MT; Geller EJ; Doll KM; Wu JM; Clarke-Pearson DL; Wheeler SB
J Minim Invasive Gynecol; 2016 Feb; 23(2):223-33. PubMed ID: 26475764
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of deep brain stimulation compared with vagus nerve stimulation and usual care for patients with refractory epilepsy: A lifetime decision analytic model.
Chan HY; Wijnen BFM; Majoie MHJM; Evers SMAA; Hiligsmann M
Epilepsia; 2022 Mar; 63(3):641-651. PubMed ID: 34967942
[TBL] [Abstract][Full Text] [Related]
9. Long-term Cost-effectiveness of Statin Treatment for Primary Prevention of Cardiovascular Disease in the Elderly.
Lin L; Teng M; Zhao YJ; Khoo AL; Seet RC; Yong QW; Yeo TC; Lim BP
Cardiovasc Drugs Ther; 2015 Apr; 29(2):187-97. PubMed ID: 25860556
[TBL] [Abstract][Full Text] [Related]
10. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of transfers to centers with neurological intensive care units after intracerebral hemorrhage.
Fletcher JJ; Kotagal V; Mammoser A; Peterson M; Morgenstern LB; Burke JF
Stroke; 2015 Jan; 46(1):58-64. PubMed ID: 25477220
[TBL] [Abstract][Full Text] [Related]
12. Probabilistic Return-on-Investment Analysis of Single-Family Versus Open-Bay Rooms in Neonatal Intensive Care Units-Synthesis and Evaluation of Early Evidence on Nosocomial Infections, Length of Stay, and Direct Cost of Care.
Sadatsafavi H; Niknejad B; Shepley M; Sadatsafavi M
J Intensive Care Med; 2019 Feb; 34(2):115-125. PubMed ID: 28118769
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness Analysis of Second-Line Chemotherapy Agents for Advanced Gastric Cancer.
Lam SW; Wai M; Lau JE; McNamara M; Earl M; Udeh B
Pharmacotherapy; 2017 Jan; 37(1):94-103. PubMed ID: 27870079
[TBL] [Abstract][Full Text] [Related]
14. Analyzing cost-effectiveness of ulnar and median nerve transfers to regain forearm flexion.
Wali AR; Park CC; Brown JM; Mandeville R
Neurosurg Focus; 2017 Mar; 42(3):E11. PubMed ID: 28245686
[TBL] [Abstract][Full Text] [Related]
15. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
[TBL] [Abstract][Full Text] [Related]
16. Age, risk, and life expectancy in Norwegian intensive care: a registry-based population modelling study.
Lindemark F; Haaland ØA; Kvåle R; Flaatten H; Johansson KA
PLoS One; 2015; 10(5):e0125907. PubMed ID: 26011281
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of non-ST-segment elevation acute coronary syndromes.
Schwenkglenks M; Brazier JE; Szucs TD; Fox KA
Value Health; 2011 Jan; 14(1):24-33. PubMed ID: 21211483
[TBL] [Abstract][Full Text] [Related]
18. The cost-effectiveness of screening for oral cancer in primary care.
Speight PM; Palmer S; Moles DR; Downer MC; Smith DH; Henriksson M; Augustovski F
Health Technol Assess; 2006 Apr; 10(14):1-144, iii-iv. PubMed ID: 16707071
[TBL] [Abstract][Full Text] [Related]
19. Hospital costs of out-of-hospital cardiac arrest patients treated in intensive care; a single centre evaluation using the national tariff-based system.
Petrie J; Easton S; Naik V; Lockie C; Brett SJ; Stümpfle R
BMJ Open; 2015 Apr; 5(4):e005797. PubMed ID: 25838503
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
